GERON CORP Increase (Decrease) in Deposits Outstanding
GERON CORP (GERN) reported Increase (Decrease) in Deposits Outstanding of -$5.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositsOutstanding · last filed 2017-03-01
- GERON CORP increase (decrease) in deposits outstanding for fiscal 2014 was -$5.00K, a 225.00% decline from fiscal 2013.
- GERON CORP increase (decrease) in deposits outstanding for fiscal 2013 was $4.00K.
- GERON CORP increase (decrease) in deposits outstanding for fiscal 2012 was -$112.00K, a 117.02% decline from fiscal 2011.
- GERON CORP increase (decrease) in deposits outstanding for fiscal 2011 was $658.00K, a 1362.22% increase from fiscal 2010.
| Period end | Increase (Decrease) in Deposits Outstanding 12 month |
|---|---|
| 2014-12-31 | -$5.00K 10-K · filed 2017-03-01 |
| 2013-12-31 | $4.00K 10-K · filed 2016-03-10 |
| 2012-12-31 | -$112.00K 10-K · filed 2015-03-11 |
| 2011-12-31 | $658.00K 10-K · filed 2014-03-17 |
| 2010-12-31 | $45.00K 10-K · filed 2013-03-15 |
| 2009-12-31 | $99.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |